Cargando...
Fingolimod
Fingolimod is the first oral disease therapy approved for relapsing-remitting multiple sclerosis (MS). Patients can be switched directly from interferon-β or glatiramer acetate to fingolimod without a washout period. Fingolimod's potent efficacy, oral route of administration, and generally good...
Gardado en:
| Publicado en: | Neurol Clin Pract |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Academy of Neurology
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5766178/ https://ncbi.nlm.nih.gov/pubmed/29443307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0b013e31823c51dd |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|